» Articles » PMID: 19700541

Development of a Single-plasmid-based Regulatable Gene Expression System for Borrelia Burgdorferi

Overview
Date 2009 Aug 25
PMID 19700541
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

We developed a single-plasmid-based regulatable protein expression system for Borrelia burgdorferi. Expression of a target gene is driven by P(ost), a hybrid B. burgdorferi ospA-tetO promoter, from a recombinant B. burgdorferi plasmid constitutively expressing TetR. The system was tested using the green fluorescent protein (GFP) as a reporter. Under noninducing conditions, recombinant B. burgdorferi cells were nonfluorescent, no GFP protein was detected, and residual, small amounts of transcript were detectable only by reverse transcription-PCR but not by Northern blot hybridization. Upon induction with anhydrotetracycline, increasing levels of GFP transcript, protein, and fluorescence were observed. This tight and titratable promoter system will be invaluable for the study of essential borrelial proteins. Since target protein, operator, and repressor are carried by a single plasmid, the system's application is independent of a particular strain background.

Citing Articles

Development of inducible promoter and CRISPRi plasmids functional in .

Nock A, Clark T, Hackstadt T J Bacteriol. 2024; 206(10):e0036724.

PMID: 39347571 PMC: 11500500. DOI: 10.1128/jb.00367-24.


Hitchhiker's Guide to .

Bourgeois J, Hu L J Bacteriol. 2024; 206(9):e0011624.

PMID: 39140751 PMC: 11411949. DOI: 10.1128/jb.00116-24.


The Consistent Tick-Vertebrate Infectious Cycle of the Lyme Disease Spirochete Enables Borrelia burgdorferi To Control Protein Expression by Monitoring Its Physiological Status.

Stevenson B, Krusenstjerna A, Castro-Padovani T, Savage C, Jutras B, Saylor T J Bacteriol. 2022; 204(5):e0060621.

PMID: 35380872 PMC: 9112904. DOI: 10.1128/jb.00606-21.


Status quo of tet regulation in bacteria.

Bertram R, Neumann B, Schuster C Microb Biotechnol. 2021; 15(4):1101-1119.

PMID: 34713957 PMC: 8966031. DOI: 10.1111/1751-7915.13926.


A selective antibiotic for Lyme disease.

Leimer N, Wu X, Imai Y, Morrissette M, Pitt N, Favre-Godal Q Cell. 2021; 184(21):5405-5418.e16.

PMID: 34619078 PMC: 8526400. DOI: 10.1016/j.cell.2021.09.011.


References
1.
Sadziene A, Barbour A, Rosa P, Thomas D . An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo. Infect Immun. 1993; 61(9):3590-6. PMC: 281052. DOI: 10.1128/iai.61.9.3590-3596.1993. View

2.
Byram R, Stewart P, Rosa P . The essential nature of the ubiquitous 26-kilobase circular replicon of Borrelia burgdorferi. J Bacteriol. 2004; 186(11):3561-9. PMC: 415784. DOI: 10.1128/JB.186.11.3561-3569.2004. View

3.
Samuels D, Mach K, Garon C . Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB. J Bacteriol. 1994; 176(19):6045-9. PMC: 196823. DOI: 10.1128/jb.176.19.6045-6049.1994. View

4.
Barbour A, Hayes S, Heiland R, Schrumpf M, Tessier S . A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun. 1986; 52(2):549-54. PMC: 261035. DOI: 10.1128/iai.52.2.549-554.1986. View

5.
Barbour A . Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med. 1984; 57(4):521-5. PMC: 2589996. View